Skip to content

Investigation of the effects of food intake on allergic symptoms

Investigation of the effects of food intake on allergic symptoms - Investigation of the effects of food intake on allergic symptoms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000061081
Enrollment
48
Registered
2026-03-27
Start date
2026-04-08
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult

Interventions

8-week intake of the test food . Take 2 tablets with water or lukewarm water once a day at breakfast

Sponsors

Macromill Carenet, Inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Japanese healthy male and female adults aged 20 years or older and under 65 years at the time of informed consent. (2) Individuals who have owned dogs or cats for at least 1 year. (3) Individuals who perceive themselves to have allergic symptoms likely caused by dogs or cats. (4) Individuals who fully understand the purpose and content of the study and agree to participate of their own free will.

Exclusion criteria

Exclusion criteria: (1) Individuals who regularly use medicines or quasi-drugs related to allergies. (2) Individuals at risk of developing allergies related to the study or the study food. (3) Individuals with nasal diseases (nasal polyps, hypertrophic rhinitis, acute or chronic rhinitis, deviated nasal septum, sinusitis, perennial rhinitis) to an extent that interferes with the evaluation of efficacy. (4) Individuals with diseases requiring constant medication (external or internal), individuals under treatment for diseases (excluding dry eye and dental caries treatment), or individuals with a history of serious diseases requiring medication. (5) Individuals with irregular lifestyle rhythms, such as shift work or late-night work. (6) Heavy drinkers. (7) Smokers. (8) Individuals with a history of abnormal clinical laboratory values or cardiopulmonary function, or a history of diseases or surgeries that may cause diabetes, glucose metabolism disorders, or lipid metabolism disorders, such as pancreatic disease, endocrine disease (including thyroid-related diseases), liver disease, or gastrectomy, and who are judged to have problems participating in the study. (9) Individuals who have participated in other clinical studies or trials within 1 month prior to the date of informed consent. (10) Individuals who expect significant changes in their living environment during the study period (travel or business trips of 1 week or more, relocation, transfer, etc.). (11) Individuals with extremely irregular eating habits. (12) Individuals judged inappropriate as study subjects by the principal investigator based on background information, pre-test results, or other reasons. (13) Individuals who are pregnant or may be pregnant, breastfeeding, or wish to become pregnant during the study period. (14) Others judged inappropriate as study subjects by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Japanese Rhinoconjunctivitis Quality of Life Questionnaire (JRQLQ No. 1)

Countries

Japan

Contacts

Public ContactSatoshi Kobayashi

Macromill Carenet, Inc. Clinical Research Solution Division

umin_info@macromillcarenet.jp03-6716-7108

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026